Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neurocrine Biosciences
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completed informed consent.
Subject has a primary diagnosis of schizophrenia.
The subject is experiencing an acute exacerbation or relapse of symptoms and currently requires hospitalization.
Subjects taking prohibited medications, including antipsychotics, must discontinue before study participation
Subject is willing and able to remain in an inpatient setting for the study duration, follow instructions, and comply with the protocol requirements.
You may not be if
An unstable medical condition, chronic disease, or malignancy.
Considered by the investigator to be at imminent risk of suicide or injury to self or others.
Diagnosis of moderate or severe substance use disorder (with the exception of nicotine or caffeine dependence) within 6 months prior to screening.
Positive alcohol test or drug screen for disallowed substances.
Have a history of poor or suspected poor compliance in clinical research studies and/or in the investigator's opinion, the subject is not capable of adhering to the protocol requirements.
